JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Activity Details


531 Wed, 8/3/2011, 12:30 PM - 1:50 PM CC-JR Ballroom D
Biopharmaceutical Section P.M. Roundtable Discussion (fee event) — Roundtables PM Roundtable Discussion
Biopharmaceutical Section
Organizer(s): Carmen Mak, Schering Plough Research Institute
WL10: Practical Use of Historical Controls in Clinical Trials for Rare Diseases Jeongsook "Jessica" Kim, U.S. Food and Drug Administration
WL11: Globalization of Clinical Trials: The Development of Treatments and Preventative Products for Diseases, with a Focus on Vaccines Tammy Massie, U.S. Food and Drug Administration
WL12: Regression with Latent Variables (MIMIC Models): A Better Way to Analyze Composite Scores from Instruments in Clinical Trials and Medical Research Chengwu Yang, Penn State University ; Barbara C. Tilley, The University of Texas Health Science Center at Houston ; Anbesaw Selassie, Medical University of South Carolina ; Ruth Greene, Johnson C. Smith University
WL13: Identifying Treatment-Effect Heterogeneity in Clinical Trials Using Subpopulation Treatment Effect Pattern Plots Ann A. Lazar, University of California at San Francisco ; Wai-ki Yip, Harvard School of Public Health ; Bernard F. Cole, University of Vermont ; Marco Bonetti, Bocconi University ; Richard D. Gelber, Harvard School of Public Health/Dana-Farber Cancer Institute
WL14: Adaptive Designs in a Confirmatory Setting Jeff Maca, Novartis
WL15: Current Issues in the Design and Analysis of Noninferiority Trials Gang Li, Johnson & Johnson Pharmaceutical R&D, LLC



2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.